The speaker is being injected with 300 million mesenchymal stem cells from young Swedish bone marrow, provided by the company Selkcoau, to rejuvenate all six major joints.

Once thawed from cryotanks, the stem cells have a limited viability of only two hours, requiring the procedure to be completed quickly before they expire.

Injecting a large number of stem cells can trigger a significant inflammatory response, causing the body to ache, feel stiff, and resulting in poor sleep with an elevated resting heart rate.

Stem cells can be administered systemically via an IV to travel throughout the body for general repair, or injected locally into a joint for a more concentrated effect.

Mesenchymal stem cells (MSCs) are like mobile paramedics, also called medicinal signaling cells, that travel to an area of injury to lower inflammation.

Before injecting new stem cells, doctors can aspirate the existing pro-inflammatory synovial fluid from the joint, based on the theory 'out with the bad, in with the good.'.

A new medical approach is to proactively treat joint deterioration seen on imaging, rather than waiting for pain or injury to occur.